Actively Recruiting
Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polypharmacy
Led by Ludwig-Maximilians - University of Munich · Updated on 2025-05-04
352
Participants Needed
3
Research Sites
183 weeks
Total Duration
On this page
Sponsors
L
Ludwig-Maximilians - University of Munich
Lead Sponsor
B
Bielefeld University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The PARTNER study is a multicentre, two-arm, pragmatic cluster-randomised trial evaluating the impact of a focused and patient-centred cooperation between general practitioners (GPs) and community pharmacists (PARTNER intervention) on reductions in the use of psychotropic, sedative and anticholinergic potentially inappropriate medication (PSA-PIM) compared to a control intervention. The PARTNER intervention comprises (1) education for health care professionals, (2) an interprofessional workshop and case conference, (3) a pharmacy visit with brown bag/medication review and patient empowerment, (4) GP practice visit with shared decision making. The control intervention only comprises a pharmacy visit with brown bag review.
CONDITIONS
Official Title
Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polypharmacy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 65 years or older
- Patient is capable of giving consent
- GP contact in the quarter prior to inclusion
- Current use of 5 or more drugs, including at least 1 psychotropic, sedative, or anticholinergic medication with treatment duration of 6 months or more
- Willingness to select a regular pharmacy for the study period
- Consent to data exchange between GP and community pharmacy
You will not qualify if you...
- Terminal illness with life expectancy less than 6 months
- Current treatment of pain associated with cancer
- Serious physical illness or mental distress making participation impossible (as assessed by GP)
- Psychiatric illness or addiction making participation impossible (as assessed by GP)
- Unable to meet study requirements such as participating in questionnaires or visits
- Current participation in other research projects on medication safety or geriatric medicine
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
University of Bielefeld
Bielefeld, Germany, 33615
Not Yet Recruiting
2
University Hospital, LMU Munich
Munich, Germany, 80336
Actively Recruiting
3
Witten/Herdecke University
Witten, Germany, 58448
Not Yet Recruiting
Research Team
T
Tobias Dreischulte, Prof. Dr.
CONTACT
A
Annette Haerdtlein
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here